Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore
About this episode
Dr. Kathleen N Moore discusses recent updates on antibody-drug conjugates for ovarian cancer treatment.
Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on available and novel treatment strategies with antibody-drug conjugates for ovarian cancer. CME information and select publications here .
More episodes of Gynecologic Oncology Update
- Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
- Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting
- Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
- Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases
- Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
- Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances
Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.